Fig. 2.

Treatment patterns of 1,191 Korean patients with chronic hepatitis C infection in the interferon-based therapy era. (A) Overall treatment initiation and withdrawal rates. Detailed information is provided in Table 3. (B) Reasons for no treatment for chronic hepatitis C. Detailed information is provided in Table 2.

Ineligible, contraindicated for antiviral therapy as judged by the attending physician; Unwillingness, patient refused antiviral treatment against the physician’s recommendation.